TODAY’S NEWS So, have we been pursuing the wrong course for GERD all this time? Is it actually caused by immune system cells, not stomach acid? Maybe cheap/old/tried-and-true really is better. …
Pharma News this week (and last)
Roche's MabThera can help extend CLL patients' lives. Meanwhile, surprisingly good results for AZ's lung cancer drug Iressa. But, disappointment for an experimental lung cancer drug being developed by …
Pharma News 10_03
Is Eli Lilly the "mystery suitor" for ImClone? - Eli Lilly & Co. is in advanced talks to buy cancer-drug developer ImClone Systems for $70 a share, or $6.1 billion, The Wall Street Journal …
Pharma News 9_26
The Sales Force Shuffle, from Pharmaceutical Executive - The last week the pharma atmosphere was abuzz with news about sales force cuts, outsourcing, and overhauls. First, Schering-Plough announced …
Pharma News 9_12
King begins hostile takeover proceedings with Alpharma - Brain Markison, King’s ceo, is disappointed that Dean Mitchell, Alpharma’s ceo, hasn’t responded to his initial offer $1.4 billion offer, which …
Pharma News 8_1
Who needs exercise? Maybe we can get the benefits in a pill! - That dream, cherished by millions of sedentary couch potatoes, just got a little bit closer. Today, researchers are reporting that an …